Bevacizumab This page contains brief information about bevacizumab and a collection of links to more information about the use of this drug, related news and research results, and ongoing clinical trials. US Brand Name(s): | ![](https://webarchive.library.unt.edu/web/20090829232521im_/http://www.cancer.gov/images/spacer.gif) | Avastin | ![](https://webarchive.library.unt.edu/web/20090829232521im_/http://www.cancer.gov/images/spacer.gif) | ![](https://webarchive.library.unt.edu/web/20090829232521im_/http://www.cancer.gov/images/spacer.gif) | FDA Approved: | ![](https://webarchive.library.unt.edu/web/20090829232521im_/http://www.cancer.gov/images/spacer.gif) | Yes |
Bevacizumab is approved by the Food and Drug Administration (FDA) to be used alone to treat glioblastoma in patients whose disease has not gotten better with other types of treatment. Bevacizumab is also approved to be used with other drugs to treat the following types of cancer: In addition to the uses that have been approved by the FDA, bevacizumab is sometimes used to treat other types of cancer. Bevacizumab is also being studied in the treatment of other types of cancer.
Information from the FDA
FDA Approval for Bevacizumab - Information from the FDA about the approval of this drug and the clinical trials that led to the approval.
Information from the NCIDefinition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Clinical Trial Results: Combining Targeted Drugs Is Worse in Colorectal Cancer (02/24/2009) - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trial Results: Bevacizumab Benefits Some Patients With Advanced Kidney Cancer (06/20/2007) - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trial Results: Adding Bevacizumab Improves Outcomes in Advanced Colorectal Cancer (05/14/2005) - Important clinical trial results for this drug, background information, and how the trial was done.
Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer (04/14/2005) - Information from the NCI Press Office about this drug.
Bevacizumab Combined With Chemotherapy Prolongs Survival for Some Patients With Advanced Lung Cancer (03/14/2005) - Information from the NCI Press Office about this drug.
Bevacizumab Combined With Oxaliplatin-Based Chemotherapy Prolongs Survival for Previously Treated Patients With Advanced Colorectal Cancer (11/29/2004) - Information from the NCI Press Office about this drug.
Bevacizumab for Treatment of Solid Tumors: Questions and Answers (08/03/2005) - Information about the use of this drug to treat cancer.
Bevacizumab May Increase Blood Clot Risk (11/18/2008) - Information about the use of this drug to treat cancer.
Information from the National Library of Medicine (NLM)
MedlinePlus Information on Bevacizumab - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. Clinical TrialsClinical Trials for Bevacizumab - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.
Important: The drug information on this Web page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
Back to Top |